News

Accused for years of copying the technologies of other countries, China now dominates the renewable energy landscape not just ...
After taking a $50 million hit in a patent lawsuit targeting its leukemia med Blincyto last year, Amgen has convinced a ...
An unexpected update to a Nintendo patent for a 3-screen DS-style device is fueling speculation for potential Switch 2 ...
After losing nearly $3 billion in research funding, Harvard University now risks losing control of its intellectual property ...
Today, Apple announced that it's restoring a version of the blood oxygen monitoring feature to affected Series 9, Series 10, ...
By combining the ETHIC bill and a legislative formulation of a withdrawn USPTO rule, Congress has an opportunity to enact ...
U.S. Secretary of Commerce Howard Lutnick on Friday, August 8, sent a letter to Harvard University President Alan Garber ...
RED BANK, NEW JERSEY / ACCESS Newswire / August 13, 2025 / Tharimmune, Inc. (Nasdaq:THAR) (“Tharimmune” or the “Company”), a clinical-stage biotechnology company dedicated to developing innovative ...
The Patent Office recently announced that it will begin enforcing a rule that requires that inter partes review (IPR) ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) on Thursday affirmed a district court’s finding on remand from an ...
Amgen convinced a federal judge in Delaware on Thursday to invalidate two patents owned by Lindis Biotech, undercutting a $50.3 million jury verdict Lindis won last year in an infringement lawsuit ...
The move is the latest escalation in the White House’s battle with the Ivy League school.